261 related articles for article (PubMed ID: 32344322)
41. Next generation sequencing based in-house HIV genotyping method: validation report.
Ayitewala A; Ssewanyana I; Kiyaga C
AIDS Res Ther; 2021 Oct; 18(1):64. PubMed ID: 34600538
[TBL] [Abstract][Full Text] [Related]
42. An in-house HIV genotyping assay for the detection of drug resistance mutations in Southeast Asian patients infected with HIV-1.
Lee CK; Lee HK; Loh TP; Sethi SK; Koay ES; Tang JW
J Med Virol; 2012 Mar; 84(3):394-401. PubMed ID: 22246824
[TBL] [Abstract][Full Text] [Related]
43. Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.
Zhou Z; Wagar N; DeVos JR; Rottinghaus E; Diallo K; Nguyen DB; Bassey O; Ugbena R; Wadonda-Kabondo N; McConnell MS; Zulu I; Chilima B; Nkengasong J; Yang C
PLoS One; 2011; 6(11):e28184. PubMed ID: 22132237
[TBL] [Abstract][Full Text] [Related]
44. Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure.
Vandenhende MA; Bellecave P; Recordon-Pinson P; Reigadas S; Bidet Y; Bruyand M; Bonnet F; Lazaro E; Neau D; Fleury H; Dabis F; Morlat P; Masquelier B
PLoS One; 2014; 9(1):e86771. PubMed ID: 24475178
[TBL] [Abstract][Full Text] [Related]
45. Clinical evaluation of a newly developed automated massively parallel sequencing assay for hepatitis C virus genotyping and detection of resistance-association variants. Comparison with a line probe assay.
Manee N; Thongbaiphet N; Pasomsub E; Chantratita W
J Virol Methods; 2017 Nov; 249():31-37. PubMed ID: 28851606
[TBL] [Abstract][Full Text] [Related]
46. Minority resistant HIV-1 variants and the response to first-line NNRTI therapy.
Nicot F; Sauné K; Raymond S; Jeanne N; Carcenac R; Lefebvre C; Cuzin L; Marchou B; Delobel P; Izopet J
J Clin Virol; 2015 Jan; 62():20-4. PubMed ID: 25542465
[TBL] [Abstract][Full Text] [Related]
47. Natural polymorphisms in HIV-1 CRF01_AE strain and profile of acquired drug resistance mutations in a long-term combination treatment cohort in northeastern China.
Sun Z; Ouyang J; Zhao B; An M; Wang L; Ding H; Han X
BMC Infect Dis; 2020 Feb; 20(1):178. PubMed ID: 32102660
[TBL] [Abstract][Full Text] [Related]
48. Next-generation sequencing of dried blood spot specimens: a novel approach to HIV drug-resistance surveillance.
Ji H; Li Y; Graham M; Liang BB; Pilon R; Tyson S; Peters G; Tyler S; Merks H; Bertagnolio S; Soto-Ramirez L; Sandstrom P; Brooks J
Antivir Ther; 2011; 16(6):871-8. PubMed ID: 21900719
[TBL] [Abstract][Full Text] [Related]
49. Performance of a high-throughput next-generation sequencing method for analysis of HIV drug resistance and viral load.
Fogel JM; Bonsall D; Cummings V; Bowden R; Golubchik T; de Cesare M; Wilson EA; Gamble T; Del Rio C; Batey DS; Mayer KH; Farley JE; Hughes JP; Remien RH; Beyrer C; Fraser C; Eshleman SH
J Antimicrob Chemother; 2020 Dec; 75(12):3510-3516. PubMed ID: 32772080
[TBL] [Abstract][Full Text] [Related]
50. Technologies for HIV-1 drug resistance testing: inventory and needs.
Metzner KJ
Curr Opin HIV AIDS; 2022 Jul; 17(4):222-228. PubMed ID: 35762377
[TBL] [Abstract][Full Text] [Related]
51. Viral evolution in the cell-associated HIV-1 DNA during early ART can lead to drug resistance and virological failure in children.
Gopalan BP; D'Souza RR; Rajnala N; Arumugam K; Dias M; Ranga U; Shet A
J Med Virol; 2019 Jun; 91(6):1036-1047. PubMed ID: 30695102
[TBL] [Abstract][Full Text] [Related]
52. An Efficient Microarray-Based Genotyping Platform for the Identification of Drug-Resistance Mutations in Majority and Minority Subpopulations of HIV-1 Quasispecies.
Martín V; Perales C; Fernández-Algar M; Dos Santos HG; Garrido P; Pernas M; Parro V; Moreno M; García-Pérez J; Alcamí J; Torán JL; Abia D; Domingo E; Briones C
PLoS One; 2016; 11(12):e0166902. PubMed ID: 27959928
[TBL] [Abstract][Full Text] [Related]
53. Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA.
Boltz VF; Rausch J; Shao W; Hattori J; Luke B; Maldarelli F; Mellors JW; Kearney MF; Coffin JM
Retrovirology; 2016 Dec; 13(1):87. PubMed ID: 27998286
[TBL] [Abstract][Full Text] [Related]
54. Low prevalence of transmitted HIV-1 drug resistance detected by a dried blood spot (DBS)-based next-generation sequencing (NGS) method in newly diagnosed individuals in Cameroon in the years 2015-16.
Mbunkah HA; Marzel A; Schmutz S; Kok YL; Zagordi O; Shilaih M; Nsanwe NN; Mbu ET; Besong LM; Sama BA; Orock E; Kouyos RD; Günthard HF; Metzner KJ
J Antimicrob Chemother; 2018 Jul; 73(7):1917-1929. PubMed ID: 29635462
[TBL] [Abstract][Full Text] [Related]
55. Sanger and Next Generation Sequencing Approaches to Evaluate HIV-1 Virus in Blood Compartments.
Arias A; López P; Sánchez R; Yamamura Y; Rivera-Amill V
Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30096879
[TBL] [Abstract][Full Text] [Related]
56. CODEHOP-Mediated PCR Improves HIV-1 Genotyping and Detection of Variants by MinION Sequencing.
Sarkhouh H; Chehadeh W
Microbiol Spectr; 2021 Oct; 9(2):e0143221. PubMed ID: 34668751
[TBL] [Abstract][Full Text] [Related]
57. HIV-1 Drug Resistance Detected by Next-Generation Sequencing among ART-Naïve Individuals: A Systematic Review and Meta-Analysis.
Ouyang F; Yuan D; Zhai W; Liu S; Zhou Y; Yang H
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400015
[TBL] [Abstract][Full Text] [Related]
58. Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations.
Ávila-Ríos S; Parkin N; Swanstrom R; Paredes R; Shafer R; Ji H; Kantor R
Viruses; 2020 Jun; 12(6):. PubMed ID: 32516949
[TBL] [Abstract][Full Text] [Related]
59. Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infection.
Nicot F; Saliou A; Raymond S; Sauné K; Dubois M; Massip P; Marchou B; Delobel P; Izopet J
J Clin Virol; 2012 Oct; 55(2):107-13. PubMed ID: 22818969
[TBL] [Abstract][Full Text] [Related]
60. Human immunodeficiency virus type 1 drug resistance testing: Evaluation of a new ultra-deep sequencing-based protocol and comparison with the TRUGENE HIV-1 Genotyping Kit.
Stelzl E; Pröll J; Bizon B; Niklas N; Danzer M; Hackl C; Stabentheiner S; Gabriel C; Kessler HH
J Virol Methods; 2011 Dec; 178(1-2):94-7. PubMed ID: 21907239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
